References
- Alcon Laboratories IncSummary of product characteristics (SPC) DuoTrav® Eye Drops SolutionHemel HempsteadAlcon Laboratories (UK) Limited2011
- SinghKShrivastavaAMedical management of glaucoma: principles and practiceIndian J Ophthalmol2011Suppl 59S889221150040
- BarnebeyHSOrengo-NaniaSFlowersBEThe safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solutionAm J Ophthalmol200514011715990081
- KonstasAGMikropoulosDHaidichABNtamposKSStewartWCTwenty-four-hour intraocular pressure control with the travoprost/timolol maleate fixed combination compared with travoprost when both are dosed in the evening in primary open-angle glaucomaBr J Ophthalmol200993448148519019932
- SchumanJSKatzGJLewisRAEfficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertensionAm J Ophthalmol2005140224225016086946
- GrossRLSullivanEKWellsDTMallickSLandryTABergaminiMVPooled results of two randomized clinical trials comparing the efficacy and safety of travoprost 0.004%/timolol 0.5% in fixed combination versus concomitant travoprost 0.004% and timolol 0.5%Clin Ophthalmol20071331732219668487
- KitazawaYSmithPSasakiNKotakeSBaeKIwamotoYTravoprost 0.004%/timolol 0.5%-fixed combination with and without benzalkonium chloride: a prospective, randomized, doubled-masked comparison of safety and efficacyEye (Lond)20112591161116921701528
- KonstasAGTsironiSVakalisANIntraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucomaActa Ophthalmol2009871717619178390
- DenisPAndrewRWellsDFrirenBA comparison of morning and evening instillation of a combination travoprost 0.004%/timolol 0.5% ophthalmic solutionEur J Ophthalmol200616340741516761242
- SuicSPLausKNDosenVMEkertMMandicZBojicLComparison of evening and morning dosing of travoprost 0.004%/timolol 0.5% fixed combination in 6 month periodColl Antropol201034384785220977071
- CentofantiMOddoneFGandolfiSComparison of travoprost and bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combinationAm J Ophthalmol2010150457558020688314
- KonstasAGMikropoulosDGEmbeslidisTA24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucomaEye (Lond)201024101606161320651749
- TeusMAMigliorSLaganovskaGEfficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertensionClin Ophthalmol2009362963619997566
- PfeifferNScherzerMLMaierHSafety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapyClin Ophthalmol2010445946620505839
- MandicZNovak-LausKBojicLSafety and efficacy of monotherapy change to fixed combination (travoprost 0.004%/timolol 0.5%) in 6 months follow up periodActa Clin Croat201049441141921830452
- ScherzerMLLiehneovaINegreteFJSchnoberDTravoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%Adv Ther201128866167021773673
- RossiGCPasinettiGMBracchinoMSwitching from concomitant latanoprost 0.005% and timolol 0.5% to a fixed combination of travoprost 0.004%/timolol 0.5% in patients with primary open-angle glaucoma and ocular hypertension: a 6-month, multicenter, cohort studyExpert Opin Pharmacother200910111705171119601697
- AndradeSCompliance in the real worldValue Health19981317117316674348
- MargoCEThe placebo effectSurv Ophthalmol1999441314410466586